Literature DB >> 12768099

Fluid resuscitation: the target from an analysis of trauma systems and patient survival.

David B Hoyt1.   

Abstract

Much can be learned from studying the deaths that occur in trauma systems as they have developed. Understanding these deaths and the potential effect of trauma systems on reducing death has major implications for designing clinical trials in fluid resuscitation. The availability of new, exciting information regarding fluid composition and physiologic effects argues for new, better-designed clinical trials. By agreeing on the form of resuscitation trials in the future, we will increase our ability to see clinically significant differences in outcome as we move from animal data to clinical efficacy.

Entities:  

Mesh:

Year:  2003        PMID: 12768099     DOI: 10.1097/01.TA.0000047221.49816.0C

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  5 in total

1.  Appropriate use of helicopters to transport trauma patients from incident scene to hospital in the United Kingdom: an algorithm.

Authors:  J J M Black; M E Ward; D J Lockey
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

Review 2.  The ebb and flow of fluid (as in resuscitation).

Authors:  K L Mattox
Journal:  Eur J Trauma Emerg Surg       Date:  2014-08-20       Impact factor: 3.693

3.  Burns, inflammation, and intestinal injury: protective effects of an anti-inflammatory resuscitation strategy.

Authors:  Todd W Costantini; Carrie Y Peterson; Lauren Kroll; William H Loomis; James G Putnam; Paul Wolf; Brian P Eliceiri; Andrew Baird; Vishal Bansal; Raul Coimbra
Journal:  J Trauma       Date:  2009-12

4.  Pyruvate dose response studies targeting the vital signs following hemorrhagic shock.

Authors:  Pushpa Sharma; Makler Vyacheslav; Chalut Carissa; Rodriguez Vanessa; Mike Bodo
Journal:  J Emerg Trauma Shock       Date:  2015 Jul-Sep

Review 5.  Clinical review: hemorrhagic shock.

Authors:  Guillermo Gutierrez; H David Reines; Marian E Wulf-Gutierrez
Journal:  Crit Care       Date:  2004-04-02       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.